Invesco’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
137,271
+19,636
| +17% | +$224K | ﹤0.01% | 2666 |
|
|
2025
Q1 | $1.4M | Buy |
117,635
+65,655
| +126% | +$780K | ﹤0.01% | 2682 |
|
|
2024
Q4 | $979K | Sell |
51,980
-361,360
| -87% | -$6.81M | ﹤0.01% | 2916 |
|
|
2024
Q3 | $9.29M | Buy |
413,340
+48,042
| +13% | +$1.08M | ﹤0.01% | 1880 |
|
|
2024
Q2 | $7.62M | Buy |
365,298
+52,388
| +17% | +$1.09M | ﹤0.01% | 1956 |
|
|
2024
Q1 | $4.6M | Buy |
312,910
+262,085
| +516% | +$3.85M | ﹤0.01% | 2288 |
|
|
2023
Q4 | $525K | Buy |
50,825
+3,421
| +7% | +$35.3K | ﹤0.01% | 3175 |
|
|
2023
Q3 | $373K | Sell |
47,404
-328
| -0.7% | -$2.58K | ﹤0.01% | 3334 |
|
|
2023
Q2 | $477K | Sell |
47,732
-702
| -1% | -$7.01K | ﹤0.01% | 3257 |
|
|
2023
Q1 | $430K | Buy |
48,434
+33,186
| +218% | +$295K | ﹤0.01% | 3329 |
|
|
2022
Q4 | $167K | Sell |
15,248
-30
| -0.2% | -$329 | ﹤0.01% | 3716 |
|
|
2022
Q3 | $199K | Buy |
15,278
+1,981
| +15% | +$25.8K | ﹤0.01% | 3661 |
|
|
2022
Q2 | $168K | Sell |
13,297
-52
| -0.4% | -$657 | ﹤0.01% | 3747 |
|
|
2022
Q1 | $187K | Buy |
13,349
+178
| +1% | +$2.49K | ﹤0.01% | 3745 |
|
|
2021
Q4 | $382K | Sell |
13,171
-2,853
| -18% | -$82.7K | ﹤0.01% | 3468 |
|
|
2021
Q3 | $480K | Buy |
16,024
+2,540
| +19% | +$76.1K | ﹤0.01% | 3418 |
|
|
2021
Q2 | $358K | Buy |
+13,484
| New | +$358K | ﹤0.01% | 3531 |
|